NCT05857878View on ClinicalTrials.gov

A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 23, 2023

Primary Completion Date

June 6, 2024

Study Completion Date

June 6, 2024

Conditions
Healthy
Interventions
DRUG

BI 1815368

BI 1815368

DRUG

Matching placebo

Matching placebo

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05857878 - A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men | Biotech Hunter | Biotech Hunter